← Back to Search

Mood Stabilizer

1 for Bipolar Disorder (LAMBS/LADS Trial)

Phase 4
Waitlist Available
Led By Caleb M Adler, MD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

LAMBS/LADS Trial Summary

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium, an FDA-approved treatment for bipolar mania, in order to better understand who benefits from treatment and why they respond to medications. Studying this may help improve treatment and outcome in patients with bipolar disorder.

Eligible Conditions
  • Bipolar Disorder

LAMBS/LADS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.

LAMBS/LADS Trial Design

2Treatment groups
Experimental Treatment
Group I: 2Experimental Treatment1 Intervention
Depressed Patients
Group II: 1Experimental Treatment1 Intervention
Manic Patients
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lithium carbonate
FDA approved
Lithium carbonate
FDA approved

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,134 Total Patients Enrolled
22 Trials studying Bipolar Disorder
1,616 Patients Enrolled for Bipolar Disorder
Caleb M Adler, MDPrincipal InvestigatorUniversity of Cincinnati
2 Previous Clinical Trials
171 Total Patients Enrolled
2 Trials studying Bipolar Disorder
171 Patients Enrolled for Bipolar Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder
Caleb M. Adler 2007. "Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00608075.
All > Obsessive Compulsive Disorder > Bipolar Disorder
~14 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top